The combination of LabelFree and RED detectors in the Monolith Pico instrument provides scientists with the ability to characterize almost any type of interaction. Where binding affinity quantification under native conditions is preferred, label-free MST can be performed. In other circumstances, measuring a labeled target is desired and the RED channel is useful for measuring any interaction, even the most challenging ones — those involving ternary complexes or interactions in cell lysate or serum — while using very little sample. Having both detectors in one instrument provides the highest versatility and flexibility of all Monolith instruments, enabling scientists to freely choose the most appropriate approach for their project.
Have a question about Monolith?
Contact SpecialistSee more related content
27:20Explore the complexities and drivers of molecular interactions with Dr. Tom Laue from the University of New Hampshire. He presented as a keynote speaker in the Protein Stability & Function: Can't have
33:11Dr. Leah Pandiscia and Dr. Daniel Turman review how to integrate the Prometheus Panta and Monolith instruments in a characterization workflow demonstration, showing how to maximize stability and funct
NanoTemper’s Monolith wins top global design award: iF DESIGN AWARD 2021
NanoTemper’s newest Monolith instrument has been awarded the globally renowned iF DESIGN AWARD 2021. User-friendly design has always been a core focus in NanoTemper’s product development....
25:40Are you struggling to tame your mischievous membrane proteins? Find out how NanoTemper can help you to characterize even the most challenging membrane protein samples. You will learn how Prometheus ca
Targeted protein degradation promises to lead the way to effective drugs for challenging targets
Quantifying the interaction of phosphite with ABC transporters: MicroScale Thermophoresis and a novel his-tag labeling approach
Are you building an effective protein degrader? 4 questions to ask yourself to find out
Protein degraders are getting a lot of attention for being a new and promising modality to treat diseases such as cancer or Alzheimer’s disease. Rather than inhibiting the function of a protein,...
Protein degraders show promising results in drug development pipelines. See what progress candidates have made.
There has been considerable and promising development in the field of targeted protein degradation (TPD) since the seminal discovery of PROTACs in 2001.1 The appeal of degraders like PROTACs lies...
6 protein degradation conferences in 2021 you can’t afford to miss
Conferences in 2021 will gather scientists and experts eager to discuss new discoveries in the emerging field of targeted protein degradation (TPD). Many transcription factors, scaffold proteins,...
59:35Bifunctional degrader molecules (also known as PROTACs) and molecular glues recruit proteins to E3 ubiquitin ligases. The formation of a ternary complex between PROTAC, ligase, and the protein of inte
1:32:25Let's catalyze - biophysical insights into enzymes
Enzymes are nature's engine for many processes. Diving into the stability and function of enzymes will give us a better understanding of these processes. In this webinar, you will learn: -what biophy
Thermophoretic analysis of ligand-specific conformational states of the inhibitory glycine receptor embedded in copolymer nanodiscs